First ever drug to slow Alzheimer’s is approved in US but experts warn caution

Aducanumab, a new Alzheimer’s drug, has been given the green light, but Professor John Hardy (UCL Queen Square Institute of Neurology) says it “will help only very carefully selected patients” and Professor Robert Howard (UCL Psychiatry) says it “represents a grave error”.

Read: FT (£), More: BBC News, Times (£), Independent, Guardian, Telegraph (£), Sky News, i News, Mirror, Economist, Irish Times, Le Monde (France), South China Morning Post, Deccan Herald (India), Herald (Scotland), Listen: BBC World Service's 'Health Check' (from 6 mins 20 secs)